What changed
$MDT — Decentralized data exchange for AI and machine learning.
🎯 Q1 FY26 | Rev $9B | EPS $1.55 vs $1.54 🟢 | Margin 24.3%
💡 Consensus expects MDT to maintain low-single-digit organic growth and face margin pressure from restructuring. The Q4 beat (EPS $1.55 vs $1.54 est) and 6.6% organic growth, especially 78% growth in Cardiac Ablation Solutions, suggest the turnaround in high-growth segments is accelerating.
🏢 Business Quality: 8/10 | Valuation: fair
📉 Reward/Risk: Upside 15% to $92 (18x forward EPS of $5.10) vs downside 10% to $72 (14x forward EPS). Ratio: 1.5:1.
🔮 Catalyst: Next quarterly report (Aug 2026): watch for organic growth >5% and non-GAAP operating margin >25%. Failure signal: organic growth <4% or margin contraction.
💰 Entry: Current price $80.25 is near the lower end of the 12-month range. Attractive for accumulation on dips to $75-78.